This product, called Illucccix, produced by Telix Pharmaceuticals ( a specialist in theranostic agents) was just approved by the Australian Therapeutic Goods Authority (similar functions as the US FDA which is still investigating it). This is big news because it enables a widespread rollout of PSMA-PET imaging using already existent instrumentation.
Australian approval for commercially ... - Advanced Prostate...
Australian approval for commercially available PSMA/Ga68 imaging agent.
Written by
kaptank
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
FDA Approves another PSMA PET scan for Prostate Cancer Imaging
onclive.com/view/fda-approves-tlx591-cdx-for-prostate-cancer-imaging
Like the other two PSMA PET...
Third PSMA PET indicator may be approved by FDA
3-a-Radiohybrid-Prostate-Specific-Membrane-Antigen-Targeted-PET-Imaging-Agent-for-Prostate-Cancer...
FDA approves Ga-68-PSMA PET scans only at UCSF and UCLA
gov/news-events/press-announcements/fda-approves-first-psma-targeted-pet-imaging-drug-men-prostate-c
Charges for GA68-PSMA-11 trials
Jonson and Sloan Kettering researching Ga 68-labeled PSMA-11...
68 Ga-PSMA scans available in USA?
company that makes the PSMA-11 \\"kit\\" indicates it is only available for \\"investigative new...